|
West Chester, PA (July 1, 2008) – Animas Corporation announced today the clearance of its OneTouch® Ping™ Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump. “OneTouch Ping provides patients the advanced insulin pump technology from Animas plus the OneTouch blood glucose technology they trust, put together into a system that offers the discretion, convenience and option of remote insulin dosing," said Juan Frias, M.D., Chief Medical Officer and Vice President of Medical Affairs, Animas Corporation. “People using OneTouch Ping will no longer have to access their pump to deliver a bolus, ultimately making life with diabetes a little easier.” OneTouch Ping also marks the first integrated product from two companies within the diabetes care group of Johnson & Johnson, Animas makers of insulin pumps and LifeScan makers of the OneTouch brand of glucose meters and OneTouch® Ultra® Test Strips. OneTouch Ping also offers the following:
ezManager® MAX Diabetes Management Software The OneTouch Ping system will also work with the recently cleared ezManager® MAX Diabetes Management Software designed to allow users to download important diabetes management data from the insulin pump and meter-remote. Integrated blood glucose data from the meter-remote and insulin dosing data may be downloaded for review, analysis and evaluation of insulin delivery and blood glucose history to better inform healthcare decision-making. The ezManager® MAX software is MAC and PC compatible. OneTouch Ping will be available for shipment in mid-August 2008. Customers can order at any time by calling 1-877-937-7867 or visit www.animascorp.com. |
|
|
West Chester, PA (July 1, 2008) – Animas Corporation announced today the clearance of its OneTouch® Ping™ Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump. “OneTouch Ping provides patients the advanced insulin pump technology from Animas plus the OneTouch blood glucose technology they trust, put together into a system that offers the discretion, convenience and option of remote insulin dosing," said Juan Frias, M.D., Chief Medical Officer and Vice President of Medical Affairs, Animas Corporation. “People using OneTouch Ping will no longer have to access their pump to deliver a bolus, ultimately making life with diabetes a little easier.” OneTouch Ping also marks the first integrated product from two companies within the diabetes care group of Johnson & Johnson, Animas makers of insulin pumps and LifeScan makers of the OneTouch brand of glucose meters and OneTouch® Ultra® Test Strips. OneTouch Ping also offers the following:
ezManager® MAX Diabetes Management Software The OneTouch Ping system will also work with the recently cleared ezManager® MAX Diabetes Management Software designed to allow users to download important diabetes management data from the insulin pump and meter-remote. Integrated blood glucose data from the meter-remote and insulin dosing data may be downloaded for review, analysis and evaluation of insulin delivery and blood glucose history to better inform healthcare decision-making. The ezManager® MAX software is MAC and PC compatible. OneTouch Ping will be available for shipment in mid-August 2008. Customers can order at any time by calling 1-877-937-7867 or visit www.animascorp.com. |